<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-30303</identifier>
<setSpec>1137-6627</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">On studies with medicines after commercialisation, obligations or prohibitions?</dc:title>
<dc:creator>Sádaba, B</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Departamento de Salud. Gobierno de Navarra</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>An Sist Sanit Navar;26(2): 187-194, mayo 2003.</dc:source>
<dc:identifier>ibc-30303</dc:identifier>
<dc:title xml:lang="es">A propósito de los estudios con fármacos tras la comercialización, ¿obligaciones o prohibiciones?</dc:title>
<dc:subject>^d11792^s22045</dc:subject>
<dc:subject>^d4403^s22066</dc:subject>
<dc:subject>^d30745^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:type>article</dc:type>
<dc:date>200305</dc:date>
</metadata>
</record>
</ibecs-document>
